nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—Levothyroxine—hypothyroidism	0.305	0.336	CbGbCtD
Acepromazine—ALB—Liothyronine—hypothyroidism	0.305	0.336	CbGbCtD
Acepromazine—ALB—Liotrix—hypothyroidism	0.298	0.328	CbGbCtD
Acepromazine—HTR2A—cerebellar cortex—hypothyroidism	0.00975	0.135	CbGeAlD
Acepromazine—DRD1—nerve—hypothyroidism	0.00917	0.127	CbGeAlD
Acepromazine—DRD2—nerve—hypothyroidism	0.00542	0.0753	CbGeAlD
Acepromazine—HTR2A—urine—hypothyroidism	0.00518	0.072	CbGeAlD
Acepromazine—HTR2A—nerve—hypothyroidism	0.00358	0.0497	CbGeAlD
Acepromazine—ALB—heart—hypothyroidism	0.00258	0.0359	CbGeAlD
Acepromazine—HTR1A—cardiovascular system—hypothyroidism	0.0021	0.0292	CbGeAlD
Acepromazine—ADRA1A—heart—hypothyroidism	0.00205	0.0285	CbGeAlD
Acepromazine—SLC22A1—blood—hypothyroidism	0.00201	0.028	CbGeAlD
Acepromazine—ADRA1A—cardiovascular system—hypothyroidism	0.00194	0.0269	CbGeAlD
Acepromazine—ALB—adrenal gland—hypothyroidism	0.00193	0.0268	CbGeAlD
Acepromazine—DRD2—pituitary gland—hypothyroidism	0.00168	0.0234	CbGeAlD
Acepromazine—HTR1A—adrenal gland—hypothyroidism	0.00166	0.0231	CbGeAlD
Acepromazine—ALB—testis—hypothyroidism	0.00159	0.0221	CbGeAlD
Acepromazine—SLC22A1—liver—hypothyroidism	0.00157	0.0219	CbGeAlD
Acepromazine—ADRA1A—adrenal gland—hypothyroidism	0.00153	0.0213	CbGeAlD
Acepromazine—ADRA1A—blood—hypothyroidism	0.00153	0.0213	CbGeAlD
Acepromazine—ALB—liver—hypothyroidism	0.00151	0.0209	CbGeAlD
Acepromazine—HTR2A—heart—hypothyroidism	0.00133	0.0184	CbGeAlD
Acepromazine—HTR1A—cerebellum—hypothyroidism	0.00127	0.0176	CbGeAlD
Acepromazine—HTR2A—cardiovascular system—hypothyroidism	0.00125	0.0174	CbGeAlD
Acepromazine—DRD2—testis—hypothyroidism	0.00124	0.0173	CbGeAlD
Acepromazine—ADRA1A—liver—hypothyroidism	0.0012	0.0166	CbGeAlD
Acepromazine—ADRA1A—cerebellum—hypothyroidism	0.00117	0.0163	CbGeAlD
Acepromazine—DRD2—cerebellum—hypothyroidism	0.00115	0.0159	CbGeAlD
Acepromazine—HTR2A—gonad—hypothyroidism	0.00114	0.0158	CbGeAlD
Acepromazine—HTR2A—pituitary gland—hypothyroidism	0.00111	0.0154	CbGeAlD
Acepromazine—HTR2A—adrenal gland—hypothyroidism	0.000991	0.0138	CbGeAlD
Acepromazine—HTR2A—blood—hypothyroidism	0.00099	0.0138	CbGeAlD
Acepromazine—HTR2A—testis—hypothyroidism	0.000819	0.0114	CbGeAlD
Acepromazine—HTR2A—liver—hypothyroidism	0.000775	0.0108	CbGeAlD
Acepromazine—HTR2A—cerebellum—hypothyroidism	0.000757	0.0105	CbGeAlD
Acepromazine—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000171	0.00874	CbGpPWpGaD
Acepromazine—HTR2A—G alpha (q) signalling events—TRH—hypothyroidism	0.000157	0.00799	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000154	0.00788	CbGpPWpGaD
Acepromazine—DRD1—G alpha (s) signalling events—AVP—hypothyroidism	0.000154	0.00785	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—TRH—hypothyroidism	0.000153	0.00783	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000144	0.00736	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00014	0.00715	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00014	0.00712	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000137	0.007	CbGpPWpGaD
Acepromazine—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.000131	0.0067	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000124	0.00635	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000124	0.00635	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00012	0.00613	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00012	0.0061	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000114	0.00583	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00011	0.00562	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00011	0.00559	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000107	0.00546	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000107	0.00546	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—TRH—hypothyroidism	0.000106	0.00543	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000105	0.00538	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—AVP—hypothyroidism	0.000105	0.00533	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000104	0.00529	CbGpPWpGaD
Acepromazine—DRD1—G alpha (s) signalling events—POMC—hypothyroidism	0.000102	0.00522	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000102	0.0052	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000102	0.0052	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000102	0.00518	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—AVP—hypothyroidism	9.51e-05	0.00485	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—TSHB—hypothyroidism	9.48e-05	0.00484	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—TSHR—hypothyroidism	9.48e-05	0.00484	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	9.4e-05	0.00479	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	9.4e-05	0.00479	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	9.25e-05	0.00472	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	9.25e-05	0.00472	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—TRH—hypothyroidism	9.14e-05	0.00467	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.08e-05	0.00463	CbGpPWpGaD
Acepromazine—ADRA1B—G alpha (q) signalling events—AVP—hypothyroidism	9.07e-05	0.00463	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	9.05e-05	0.00462	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	9.05e-05	0.00462	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—TRH—hypothyroidism	8.71e-05	0.00444	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	8.62e-05	0.0044	CbGpPWpGaD
Acepromazine—HTR2A—G alpha (q) signalling events—AVP—hypothyroidism	8.23e-05	0.0042	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—TSHB—hypothyroidism	8.15e-05	0.00416	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—TSHR—hypothyroidism	8.15e-05	0.00416	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	8.11e-05	0.00414	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	8.06e-05	0.00411	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—TRH—hypothyroidism	8.03e-05	0.0041	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—TRH—hypothyroidism	7.9e-05	0.00403	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—AVP—hypothyroidism	7.89e-05	0.00403	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—TSHB—hypothyroidism	7.76e-05	0.00396	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—TSHR—hypothyroidism	7.76e-05	0.00396	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	7.73e-05	0.00395	CbGpPWpGaD
Acepromazine—ALB—Platelet degranulation—IGF1—hypothyroidism	7.45e-05	0.0038	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—IYD—hypothyroidism	7.4e-05	0.00378	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	7.36e-05	0.00375	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	7.34e-05	0.00374	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.33e-05	0.00374	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	7.21e-05	0.00368	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—TSHB—hypothyroidism	7.16e-05	0.00365	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—TSHR—hypothyroidism	7.16e-05	0.00365	CbGpPWpGaD
Acepromazine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	7.1e-05	0.00362	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	7.04e-05	0.00359	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	7.04e-05	0.00359	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	6.89e-05	0.00352	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	6.89e-05	0.00352	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.78e-05	0.00346	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.31e-05	0.00322	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ATP5O—hypothyroidism	6.29e-05	0.00321	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.07e-05	0.0031	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—TRH—hypothyroidism	6.01e-05	0.00307	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.01e-05	0.00306	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—TPO—hypothyroidism	5.92e-05	0.00302	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.76e-05	0.00294	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—AVP—hypothyroidism	5.59e-05	0.00285	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.54e-05	0.00283	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—TRH—hypothyroidism	5.46e-05	0.00278	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.45e-05	0.00278	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	5.36e-05	0.00274	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—TSHB—hypothyroidism	5.36e-05	0.00273	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—TSHR—hypothyroidism	5.36e-05	0.00273	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.34e-05	0.00272	CbGpPWpGaD
Acepromazine—HTR1A—G alpha (i) signalling events—POMC—hypothyroidism	5.27e-05	0.00269	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—TRH—hypothyroidism	5.17e-05	0.00264	CbGpPWpGaD
Acepromazine—ALB—Metabolism—IYD—hypothyroidism	4.95e-05	0.00253	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—TRH—hypothyroidism	4.92e-05	0.00251	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.87e-05	0.00249	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—TSHB—hypothyroidism	4.86e-05	0.00248	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—TSHR—hypothyroidism	4.86e-05	0.00248	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—AVP—hypothyroidism	4.8e-05	0.00245	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—TRH—hypothyroidism	4.69e-05	0.00239	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	4.63e-05	0.00236	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—TSHB—hypothyroidism	4.61e-05	0.00235	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—TSHR—hypothyroidism	4.61e-05	0.00235	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—AVP—hypothyroidism	4.57e-05	0.00233	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.54e-05	0.00232	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	4.54e-05	0.00231	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—TRH—hypothyroidism	4.47e-05	0.00228	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	4.46e-05	0.00228	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—TSHB—hypothyroidism	4.39e-05	0.00224	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—TSHR—hypothyroidism	4.39e-05	0.00224	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.38e-05	0.00223	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	4.37e-05	0.00223	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—AVP—hypothyroidism	4.22e-05	0.00215	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ATP5O—hypothyroidism	4.21e-05	0.00215	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.19e-05	0.00214	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—TSHB—hypothyroidism	4.18e-05	0.00213	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—TSHR—hypothyroidism	4.18e-05	0.00213	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—AVP—hypothyroidism	4.15e-05	0.00212	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—TRH—hypothyroidism	4.12e-05	0.0021	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	4.06e-05	0.00207	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—TRH—hypothyroidism	4.05e-05	0.00207	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	4.04e-05	0.00206	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	4.04e-05	0.00206	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—SH2B3—hypothyroidism	4.03e-05	0.00206	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.99e-05	0.00204	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	3.98e-05	0.00203	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	3.98e-05	0.00203	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	3.98e-05	0.00203	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	3.98e-05	0.00203	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	3.97e-05	0.00203	CbGpPWpGaD
Acepromazine—ALB—Metabolism—TPO—hypothyroidism	3.96e-05	0.00202	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	3.9e-05	0.00199	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	3.9e-05	0.00199	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CLTC—hypothyroidism	3.73e-05	0.0019	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—POMC—hypothyroidism	3.71e-05	0.00189	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.68e-05	0.00188	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	3.67e-05	0.00187	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	3.67e-05	0.00187	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.67e-05	0.00187	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.62e-05	0.00185	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	3.61e-05	0.00184	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	3.61e-05	0.00184	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.55e-05	0.00181	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	3.54e-05	0.00181	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	3.54e-05	0.00181	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.45e-05	0.00176	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.3e-05	0.00169	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	3.28e-05	0.00167	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TRH—hypothyroidism	3.22e-05	0.00164	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CLTC—hypothyroidism	3.21e-05	0.00164	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—POMC—hypothyroidism	3.19e-05	0.00163	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AVP—hypothyroidism	3.16e-05	0.00161	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	3.05e-05	0.00156	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	3.04e-05	0.00155	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—VAV3—hypothyroidism	2.98e-05	0.00152	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.93e-05	0.00149	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TSHB—hypothyroidism	2.87e-05	0.00147	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TSHR—hypothyroidism	2.87e-05	0.00147	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AVP—hypothyroidism	2.87e-05	0.00146	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	2.82e-05	0.00144	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CLTC—hypothyroidism	2.82e-05	0.00144	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—POMC—hypothyroidism	2.8e-05	0.00143	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TRH—hypothyroidism	2.77e-05	0.00141	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	2.77e-05	0.00141	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—VAV3—hypothyroidism	2.77e-05	0.00141	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	2.76e-05	0.00141	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—TSHB—hypothyroidism	2.74e-05	0.0014	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	2.71e-05	0.00138	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	2.71e-05	0.00138	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	2.7e-05	0.00138	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	2.68e-05	0.00137	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TRH—hypothyroidism	2.64e-05	0.00135	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	2.59e-05	0.00132	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SH2B3—hypothyroidism	2.56e-05	0.00131	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	2.56e-05	0.00131	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	2.47e-05	0.00126	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TSHB—hypothyroidism	2.47e-05	0.00126	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TSHR—hypothyroidism	2.47e-05	0.00126	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AVP—hypothyroidism	2.47e-05	0.00126	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	2.44e-05	0.00125	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	2.44e-05	0.00124	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	2.43e-05	0.00124	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TRH—hypothyroidism	2.43e-05	0.00124	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TRH—hypothyroidism	2.39e-05	0.00122	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	2.38e-05	0.00122	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	2.38e-05	0.00122	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	2.35e-05	0.0012	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	2.35e-05	0.0012	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	2.35e-05	0.0012	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	2.35e-05	0.0012	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TRH—hypothyroidism	2.34e-05	0.0012	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.31e-05	0.00118	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	2.3e-05	0.00117	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	2.25e-05	0.00115	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	2.21e-05	0.00113	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	2.2e-05	0.00112	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TSHB—hypothyroidism	2.17e-05	0.00111	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TSHR—hypothyroidism	2.17e-05	0.00111	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	2.16e-05	0.0011	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AVP—hypothyroidism	2.16e-05	0.0011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	2.13e-05	0.00109	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	2.13e-05	0.00109	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	2.13e-05	0.00109	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—POMC—hypothyroidism	2.1e-05	0.00107	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	2.1e-05	0.00107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	2.09e-05	0.00107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	2.09e-05	0.00107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	2.09e-05	0.00106	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—SLC5A5—hypothyroidism	2.05e-05	0.00105	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	1.93e-05	0.000987	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—POMC—hypothyroidism	1.9e-05	0.000972	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	1.9e-05	0.000971	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PRL—hypothyroidism	1.9e-05	0.000969	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	1.86e-05	0.00095	CbGpPWpGaD
Acepromazine—ALB—Metabolism—TSHB—hypothyroidism	1.83e-05	0.000935	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	1.8e-05	0.00092	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—VAV3—hypothyroidism	1.76e-05	0.000897	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	1.72e-05	0.000876	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IGF1—hypothyroidism	1.7e-05	0.000869	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AVP—hypothyroidism	1.69e-05	0.000864	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	1.64e-05	0.000836	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PRL—hypothyroidism	1.63e-05	0.000834	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3C2A—hypothyroidism	1.63e-05	0.000833	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.61e-05	0.000822	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	1.58e-05	0.000808	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	1.56e-05	0.000796	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	1.56e-05	0.000795	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PRL—hypothyroidism	1.56e-05	0.000794	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	1.53e-05	0.000779	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	1.51e-05	0.000771	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AVP—hypothyroidism	1.46e-05	0.000743	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	1.44e-05	0.000734	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—POMC—hypothyroidism	1.44e-05	0.000734	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PRL—hypothyroidism	1.43e-05	0.000732	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	1.42e-05	0.000722	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PRL—hypothyroidism	1.41e-05	0.00072	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AVP—hypothyroidism	1.39e-05	0.000708	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	1.39e-05	0.000707	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	1.38e-05	0.000705	CbGpPWpGaD
Acepromazine—ALB—Metabolism—SLC5A5—hypothyroidism	1.37e-05	0.0007	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—VAV3—hypothyroidism	1.33e-05	0.000677	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	1.31e-05	0.000666	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	1.28e-05	0.000652	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AVP—hypothyroidism	1.28e-05	0.000652	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AVP—hypothyroidism	1.26e-05	0.000642	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	1.23e-05	0.000628	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—POMC—hypothyroidism	1.13e-05	0.000574	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IGF1—hypothyroidism	1.08e-05	0.000552	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—POMC—hypothyroidism	1.07e-05	0.000548	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—POMC—hypothyroidism	9.68e-06	0.000494	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	9.31e-06	0.000475	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—POMC—hypothyroidism	9.22e-06	0.00047	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	8.86e-06	0.000452	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—POMC—hypothyroidism	8.5e-06	0.000433	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—POMC—hypothyroidism	8.36e-06	0.000427	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	8.19e-06	0.000418	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF1—hypothyroidism	8.17e-06	0.000417	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	8.04e-06	0.00041	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	7.87e-06	0.000402	CbGpPWpGaD
Acepromazine—ALB—Metabolism—POMC—hypothyroidism	7.18e-06	0.000366	CbGpPWpGaD
